Article Details
Retrieved on: 2018-03-01 01:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... the biopharmaceutical company's stock worth $1,174,000 after acquiring an additional 1,366,924 shares during the last quarter. <b>Renaissance Technologies</b> LLC purchased a new stake in Palatin Technologies during the 4th quarter valued at $1,456,000. Finally, Arrowstreet Capital Limited Partnership ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here